Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Angoulvant

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Ebiomedicine|August 26, 2023
Seeing the invisible with ultrasound-based imaging to reveal live myocardial no reflow. A clinician perspectiveDenis Angoulvant
European Journal of Preventive Cardiology|February 25, 2025
Towards Personalized Prevention: The Role of ECG in Cardiovascular Risk Prediction for Type 2 DiabetesArnaud Bisson, Denis Angoulvant
European Journal of Preventive Cardiology|June 24, 2024
Incremental progress but still far from good enough: real-world LDL-cholesterol insights from the SANTORINI 1-year follow-up studyMayank Dalakoti, Denis Angoulvant
European Journal of Preventive Cardiology|April 12, 2026
Beyond the Usual Suspects: Rethinking Cardiovascular Risk in the SMuRF-less EraLauriane Benoist, Denis Angoulvant
Medecine Sciences : M/S|January 7, 2020
[Monoclonal antibodies in cardiovascular diseases and metabolic disorders today]Denis Angoulvant, Atul Pathak
Therapie|August 29, 2016
False positive results in preclinical researchDenis Angoulvant, Theodora Bejan-Angoulvant
Archives of Cardiovascular Diseases|October 28, 2018
The best in coronary artery disease management is yet to comeDenis Angoulvant, Theodora Bejan-Angoulvant
Archives of Cardiovascular Diseases|July 4, 2025
The dawn of in silico clinical trials in cardiovascular diseases: Lessons from the SIRIUS programmeDenis Angoulvant, Jean-Pierre Boissel
The New England Journal of Medicine|January 27, 2021
Empagliflozin in Heart FailureLaurent Fauchier, Grégoire Fauchier, Denis Angoulvant
The New England Journal of Medicine|February 12, 2025
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationNathan Mewton, Denis Angoulvant, Claire Bouleti
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Ebiomedicine|August 26, 2023
Seeing the invisible with ultrasound-based imaging to reveal live myocardial no reflow. A clinician perspectiveDenis Angoulvant
European Journal of Preventive Cardiology|February 25, 2025
Towards Personalized Prevention: The Role of ECG in Cardiovascular Risk Prediction for Type 2 DiabetesArnaud Bisson, Denis Angoulvant
European Journal of Preventive Cardiology|June 24, 2024
Incremental progress but still far from good enough: real-world LDL-cholesterol insights from the SANTORINI 1-year follow-up studyMayank Dalakoti, Denis Angoulvant
European Journal of Preventive Cardiology|April 12, 2026
Beyond the Usual Suspects: Rethinking Cardiovascular Risk in the SMuRF-less EraLauriane Benoist, Denis Angoulvant
Medecine Sciences : M/S|January 7, 2020
[Monoclonal antibodies in cardiovascular diseases and metabolic disorders today]Denis Angoulvant, Atul Pathak
Therapie|August 29, 2016
False positive results in preclinical researchDenis Angoulvant, Theodora Bejan-Angoulvant
Archives of Cardiovascular Diseases|October 28, 2018
The best in coronary artery disease management is yet to comeDenis Angoulvant, Theodora Bejan-Angoulvant
Archives of Cardiovascular Diseases|July 4, 2025
The dawn of in silico clinical trials in cardiovascular diseases: Lessons from the SIRIUS programmeDenis Angoulvant, Jean-Pierre Boissel
The New England Journal of Medicine|January 27, 2021
Empagliflozin in Heart FailureLaurent Fauchier, Grégoire Fauchier, Denis Angoulvant
The New England Journal of Medicine|February 12, 2025
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationNathan Mewton, Denis Angoulvant, Claire Bouleti
Pageof 22